Rankings
▼
Calendar
ALT FY 2010 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$329M
FY 2010 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$21M
-23.8% YoY
Gross Profit
$21M
100.0% margin
Operating Income
-$24M
-112.2% margin
Net Income
-$35M
-166.0% margin
EPS (Diluted)
$-323.59
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$27M
Total Liabilities
$15M
Stockholders' Equity
$12M
Cash & Equivalents
$12M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$28M
-23.8%
Gross Profit
$21M
$28M
-23.8%
Operating Income
-$24M
-$26M
+9.3%
Net Income
-$35M
-$32M
-8.0%
← FY 2009
All Quarters
FY 2011 →